Christopher Rovaldi, SVP, Program Management and Operations at ACCELERON PHARMA INC (XLRN), sold 12,735 shares at $38.32 ($488K) on 2017-09-12, disclosed to the SEC on 2017-09-14.
Open-market sale of $488k XLRN by SVP, Program Management and Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| XLRN | SELL | 2018-04-04 | $245K | — | Filing → |
| XLRN | SELL | 2018-01-17 | $495K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $157K | — | Filing → |